Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07510048 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combatting HIV Or Other STIs Early (CHOOSE)

Study acronym: CHOOSE
StatusRecruiting
PhaseNot applicable
SponsorWestat
Started
View on ClinicalTrials.gov ↗

Record History

  1. Phase changed: Phase 2 → not applicable Recruitment opened · Start date changed from estimate of Jul 20, 2026 to Sep 16, 2026 · Eligibility criteria expanded, about 19 words · 3 more Show 6 more changesShow less
    • Recruitment opened
    • Start date changed from estimate of Jul 20, 2026 to Sep 16, 2026
    • Eligibility criteria expanded, about 19 words
    • Secondary endpoints: details revised at 3 of 4 entries
    • Study description revised
    • Site details revised at 6 of 6 sites
  2. Start date: Apr 2026 to Jul 20, 2026 Primary and study completion moved earlier from Sep 2029 to Mar 30, 2029v3 Show 1 more changeShow less
    • Primary and study completion moved earlier from Sep 2029 to Mar 30, 2029
  3. Study title shortened, about 7 wordsv2 See this version in full on ClinicalTrials.gov ↗
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Westat
6 trials monitored
See 1 trial at risk
The overarching goal of this project is to optimize the PrEP Choice integrated mHealth package and assess the efficacy and cost of PrEP Choice on PrEP initiation and adherence among young people. It is hypothesized that PrEP Choice will improve HIV PrEP uptake and adherence among young people and will be cost-effective to deliver to young people in the United States (U.S.). This study will also assess the uptake, adherence, and acceptability of DoxyPEP among young people.
Trial Details
NCT Number NCT07510048
Lead Sponsor Westat
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH), National Institutes of Health (NIH), Florida State University, The Emmes Company, LLC
Conditions HIV, STIs, STIs Prevention, HIV Prevention
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov